ArticleBMC public health2025
Coverage and predictors of full measles-rubella immunization among children aged 24-59 months in Northern Ghana: a post measles outbreak assessment.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionVaccination plays a critical role in ensuring the health, survival, and well-being of children worldwide. It is one of the most cost-effective and scientifically proven public health interventions that protect children from severe and life-threatening diseases. Despite efforts to improve measles vaccination coverage in the five Northern regions of Ghana, less than 70% complete vaccination coverage leaves these areas vulnerable to outbreaks. To fill this gap, our study explores the predictors of complete measles immunization coverage among children aged 24-59 months in Northern Ghana.
methodsA community-based cross-sectional study was conducted from June to September 2023. Data was collected from caregivers of children aged 24-59 months. A sample size of 636 children with a multistage sampling technique was used. We collected data from the caregivers using a semi-structured questionnaire and a data abstraction tool. Logistic regression was used to assess the factors associated with measles vaccine uptake at a 5% significance level.
resultsAmong the 617 children, 61.1% (0.57-0.65) were fully vaccinated against measles. The first dose of the measles-rubella vaccine was received by 87.7% (95% CI: 0.84-0.90) of the children. After adjusting for potential confounders, regression models showed that the awareness (aOR = 2.91, 95% CI:1.35-6.25), high knowledge level (aOR = 8.27, 95% CI:3.02-22.71), ANC (aOR = 2.48, 95% CI:1.11-5.52), side effects (aOR = 0.04, 95% CI:0.02-0.08) and receiving other childhood vaccines (aOR = 3.27, 95%CI:1.80-5.94) were significantly associated with the uptake of measles-rubella vaccines in Northern Ghana.
conclusionThe uptake of the second dose of the measles-rubella vaccine in Northern Ghana was below the recommended 95% by the WHO. Awareness of the vaccine, knowledge level, ANC attendance, receiving other vaccines, and perceived side effects were the main predictors of measles vaccine uptake in the region. Ghana Health Service should intensify sensitization and awareness creation at the community level.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.